J Neurol Surg B Skull Base 2016; 77(04): 333-340
DOI: 10.1055/s-0035-1571166
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Hearing Outcomes after Middle Fossa or Retrosigmoid Craniotomy for Vestibular Schwannoma Tumors

Eric P. Wilkinson
1   House Clinic, Los Angeles, California, United States
,
Daniel S. Roberts
1   House Clinic, Los Angeles, California, United States
,
Adam Cassis
2   Department of Otolaryngology, West Virginia University Hospital, Morgantown, West Virginia, United States
,
Marc S. Schwartz
1   House Clinic, Los Angeles, California, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

11. November 2015

24. November 2015

Publikationsdatum:
13. Februar 2016 (online)

Preview

Abstract

Objective The objective of this study was to evaluate hearing outcomes following middle fossa (MF) or retrosigmoid (RS) craniotomy for vestibular schwannoma (VS) removal with the goal of hearing preservation.

Design This is a retrospective series.

Setting This study was set at a skull base referral center.

Participants In this study, 377 sporadic VS patients underwent primary microsurgery for VS from 2002 to 2012 using the MF (n = 305) or RS (n = 72) approaches.

Main Outcome Measures The main outcome measures were change in pure-tone average (PTA) and word recognition score from pre- to postoperative and surgical complications.

Results Preoperative hearing did not differ between approaches. Tumors were larger in the RS group (mean = 1.78 cm) than the MF group (mean = 0.97 cm) (p ≤ 0.001). Mean times to last audiometric follow-up were MF 1.0 year and RS 0.7 years. Mean decline in hearing from preoperative to last follow-up was greater in the RS group (55.5 dB in PTA and 45.6% in discrimination) than the MF group (38.9 dB and 31.7%) (p ≤ 0.011 and 0.033, respectively). The effect of surgical approach on hearing outcome remained after controlling for tumor size. Facial nerve outcomes and cerebrospinal fluid leak rates were not significantly different.

Conclusion Loss of hearing was greater with the RS approach than the MF approach, even when accounting for differences in tumor size. Postoperative facial nerve function and other complications did not differ between approaches.

Note

Eric P. Wilkinson and Daniel S. Roberts contributed equally.